We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Global X Genomics and Biotechnology | NASDAQ:GNOM | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.19 | 1.96% | 9.89 | 9.53 | 11.02 | 9.93 | 9.63 | 9.63 | 111,673 | 05:00:05 |
P.O. Box 9012 Clearwater, Florida 33758-9012 (727) 299-1800 |
March 18, 2013
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
VIA EDGAR
RE: | Transamerica Partners Funds Group II (the Registrant) |
( File Nos. 333-00295; 811-07495) |
Ladies and Gentlemen:
On behalf of the Transamerica Partners Funds Group II and pursuant to Rule 497(e) under the Securities Act of 1933, as amended, attached for filing are exhibits containing interactive data format risk/return summary information of the prospectus dated May 1, 2012, as supplemented February 27, 2013 for the Transamerica Partner Institutional Money Market (the Fund), a series of the Registrant, as filed under Rule 497 on February 27, 2013 (SEC Accession No. 0001193125-13-079566). The purpose of this filing is to submit the requisite prospectus risk/return disclosures in XBRL for the Fund.
Please direct any questions concerning this filing to the undersigned at (727) 299-1844.
Sincerely,
/s/ Timothy J. Bresnahan
Timothy J. Bresnahan
Assistant Secretary
1 Year Global X Genomics and Bi... Chart |
1 Month Global X Genomics and Bi... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions